The Valley Desk

NCT03493685 · Interventional trial

Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

Overall registry status Completed

Phase 3

Conditions Focal Segmental Glomerulosclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov